Goldman Sachs Group Analysts Give Bayer (FRA:BAYN) a €77.00 Price Target

Share on StockTwits

Goldman Sachs Group set a €77.00 ($89.53) price target on Bayer (FRA:BAYN) in a research note published on Monday morning, Borsen Zeitung reports. The brokerage currently has a buy rating on the healthcare company’s stock.

BAYN has been the topic of several other research reports. Barclays set a €85.00 ($98.84) price target on Bayer and gave the company a buy rating in a research note on Tuesday, July 30th. Berenberg Bank set a €67.00 ($77.91) price target on Bayer and gave the company a neutral rating in a research note on Wednesday, July 31st. Kepler Capital Markets set a €70.00 ($81.40) price target on Bayer and gave the company a neutral rating in a research note on Thursday, June 27th. Warburg Research set a €61.00 ($70.93) price target on Bayer and gave the company a neutral rating in a research note on Wednesday, August 7th. Finally, Independent Research set a €53.00 ($61.63) price target on Bayer and gave the company a sell rating in a research note on Thursday, August 1st. One analyst has rated the stock with a sell rating, eleven have given a hold rating and twelve have given a buy rating to the stock. Bayer currently has an average rating of Hold and an average target price of €80.57 ($93.68).

Bayer stock opened at €62.98 ($73.23) on Monday. The business has a fifty day simple moving average of €59.42. Bayer has a 52 week low of €91.58 ($106.49) and a 52 week high of €123.82 ($143.98).

Bayer Company Profile

Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, Crop Science, and Animal Health segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents.

See Also: What is an investor looking for in an SEC filing?

Analyst Recommendations for Bayer (FRA:BAYN)

Receive News & Ratings for Bayer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.